From this week’s newsletter, Food Allergy & Anaphylaxis Network is funding a study on suppressing peanut allergy. I’ll be walking to raise funds for the organization next month, and this is just one of the reasons why.

We are pleased to announce that FAAN is funding a final phase of a clinical study focusing on the safety and efficacy of oral and sublingual immunotherapy in children with peanut allergy. The study is led by Robert A. Wood, M.D., a professor of pediatrics and international health and director of Pediatric Allergy and Immunology at Johns Hopkins University School of Medicine in Baltimore. Dr. Wood’s team aims to better understand the complexities of the mechanisms of desensitization and long-term tolerance. This final phase of the study will enable Dr. Wood and his team to conduct additional laboratory studies that may help researchers understand which patients will respond to these therapies.

FAAN’s Research Grant Program has awarded more than $5 million since 2004 to scientists advancing research in the field of food allergy.

Donate or join our team if you’d like to help!

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.